Teaching and learning curriculum programs: recommendations for postgraduate pharmacy experiences in education

Eric A Wright1, Bonnie Brown2, Jacob Gettig2

  • 1Eric A. Wright, Pharm.D., BCPS, is Associate Professor, Nesbitt College of Pharmacy and Nursing, Wilkes University, Wilkes-Barre, PA. Bonnie Brown, Pharm.D., is Assistant Dean of Student Affairs, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN. Jacob Gettig, Pharm.D., M.P.H., BCPS, is Assistant Dean for Postgraduate Education and Associate Professor, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL. Jay L. Martello, Pharm.D., BCPS, is Clinical Assistant Professor, School of Pharmacy, West Virginia University Morgantown. Katie S. McClendon, Pharm.D., BCPS, is Clinical Assistant Professor, School of Pharmacy, University of Mississippi, Jackson. Kelly M. Smith, Pharm.D., BCPS, FASHP, FCCP, is Associate Dean, Academic and Student Affairs, and Associate Professor, Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington. Janet Teeters, M.S., is Director, Accreditation Services, American Society of Health-System Pharmacists, Bethesda, MD. Timothy R. Ulbrich, Pharm.D., is Director, Pharmacy Resident Education, and Assistant Professor of Pharmacy Practice, College of Pharmacy, Northeast Ohio Medical University, Rootstown. Nicole Wegrzyn, Pharm.D., is Assistant Professor, School of Pharmacy, Pacific University Hillsboro, OR. Lynette R. Bradley-Baker, B.S.Pharm., Ph.D., is Director, Professional Alliance Development, American Association of Colleges of Pharmacy, Alexandria, VA. eric.wright@wilkes.edu.

Summary

Postgraduate pharmacy programs should develop teaching and learning curriculum (TLC) experiences. These programs offer valuable teaching skills for practitioners and academicians, requiring transparency and systematic assessment for optimal participant outcomes.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation01:20

Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation

Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
2.4K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
597
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation01:24

Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation

Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400